Table 1 Patient characteristics and treatments
Patient No. | Age (years) | Gender | Pathology | AV (cm) | Initial stage* | MRF involvement | DM site | Preoperative treatment |
|---|---|---|---|---|---|---|---|---|
1 | 52 | M | Adeno MD | 7.8 | T4aN1M1a | + | Liver | E-FOLFOX #9 + RT (25 Gy/5fx) + E-FOLFOX #3 |
2 | 39 | F | Adeno MD | 7 | T4aN0M1b | + | Peritoneum, Lt. ovary | A-FOLFOX #7 + RT (25 Gy/5fx) + A-FOLFOX #2 |
3 | 56 | M | Adeno MD | 4 | T3N2aM1a | + | Liver | FOLFOX #4 + RT (25 Gy/5fx) + FOLFOX #4 |
4 | 45 | F | Adeno WD | 8 | T3N2aM1a | Threatened | Liver, both ovaries | FOLFOX #4 + RT (25 Gy/5fx) |
5 | 63 | M | Adeno MD | 1 | T4N1aM1a | + | Liver | FOLFOX #4 + RT (25 Gy/5fx) + FOLFOX #4 |
6 | 60 | M | Adeno MD | 7 | T3N2bM1a | + | Liver | FOLFOX #4 + RT (25 Gy/5fx) + FOLFOX #5 |